Showing results (1921-1930 of 5,856) with videos related to
Sort By:
Pageof 586
Current Opinion in Investigational Drugs (London, England : 2000)|August 31, 2001
The use of CpG DNA as a mucosal vaccine adjuvantM J McCluskie, R D Weeratna, P J Payette, et al.Vaccine|June 8, 2001
Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvantsM J McCluskie, R D Weeratna, J D Clements, et al.Women & Health|September 27, 2000
Mothers with HIV/AIDS and their children: disclosure and guardianship issuesJ M Simoni, M L Davis, J A Drossman, et al.Journal of Medicinal Chemistry|September 9, 2000
Synthesis and biological activity of a novel 11a-homo (cyclohexyl) prostaglandinP G Klimko, T L Davis, B W Griffin, et al.Movement Disorders Clinical Practice|February 5, 2019
Delusional Infestation in Parkinson's DiseaseJennie L Davis, Julie A Kurek, Kapil D Sethi, et al.Journal of Fluorescence|December 30, 2004
Photoluminescence properties of conjugated phenylacetylene monodendrons in thin filmsJoseph S Melinger, Benjamin L Davis, Dale McMorrow, et al.Vaccine|August 6, 2005
TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)Risini D Weeratna, Shawn R Makinen, Michael J McCluskie, et al.Ophthalmology|February 1, 1994
Ophthalmic findings in scleromyxedemaM L Davis, G B Bartley, L E Gibson, et al.FEMS Immunology and Medical Microbiology|April 6, 2002
Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNAMichael J McCluskie, Risini D Weeratna, Paul J Payette, et al.Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 11, 1992
Arterial blood gases and brain oxygen availability following infusion of intratracheal fluorocarbon neat liquidsR E Hoffmann, H K Bhargava, S L Davis, et al.Pageof 586